HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

916.699

-8.566-0.93%

Number of Gainers:6

Number of Losers:9

Number of Flat:2

PE:- -

High:925.384

Open:925.265

Low:913.375

Close:925.265

Volume:260.39M

Turnover:2.37B

Market Cap:616.77B

Float Cap:513.79B

Loading ...

BYD Electronic (International) Stock Sheds 1.7% in Hong Kong

CSPC Pharmaceutical Group Stock Climbs 2.2% in Hong Kong, Outperforms Competitors

JD Health International Stock Falls 3.5% in Hong Kong

Sinopharm Group Stock Falls 1.9% in Hong Kong

Alibaba Health Information Technology Stock Slips 3.7% in Hong Kong

AH Share Premium Rankings: Market Close Update for August 24

Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion

Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results

Hong Kong Stock Flash | Baiyunshan (00874) Drops Nearly 6% After Results, Net Profit Falls 16.7% in H1 Due to Higher R&D Spending

Ascletis Pharma Slips on Expecting Deeper H1 Loss on R&D Expenses

Sinopharm Group's Profit Declines 2% in H1

MT Newswires Live

Guangzhou Baiyunshan Pharma's Profit Falls 17% in H1

MT Newswires Live

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors

Sinopharm Group H1 Revenue RMB 282,799.6 Million

THOMSON REUTERS

Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion

JD Health International (SEHK:6618) Could Be 43% Undervalued As Half Year Profit Rises

Simply Wall St.

Dunhuang's Medical Heritage Blends into Tourism, Boosting Wellness Travel Along the Silk Road

mRNA Vaccine Breakthrough: From Prevention to Treatment, a Historic Leap in Oncology

Weak Dollar and Shifting Tech Narratives: Strategists Favor Resources and Pharma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1515/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":916.6986,"timestamp":1788250091886,"preClose":925.2649,"halted":0,"volume":260393918,"delay":0,"changeRate":-0.009258,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-8.566284,"latestTime":"09-01 16:00:00","open":925.2649,"high":925.38446,"low":913.3745,"amount":2367757160.5,"amplitude":0.01298,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":1.389189,"peRate":17.860083,"turnoverRate":0.003323,"increases":5,"decrements":9,"flats":3,"marketCap":616771750720,"floatMarketCap":513789278016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":925.38446,"amplitude":0.01298,"preClose":925.2649,"low":913.3745,"pbRate":"1.389189","latestPrice":916.6986,"volume":260393918,"delay":0,"open":925.2649,"prevYearClose":1190.107,"prevWeekClose":933.888,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":935.94,"twentyDayClose":925.982,"sixtyDayClose":907.099,"secType":"PLATE","market":"HK","turnoverRate":0.003323,"peRate":17.860083,"marketCap":616771750720,"floatMarketCap":513789278016,"timestamp":1788250091886,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":9,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661822143","title":"BYD Electronic (International) Stock Sheds 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661822143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661822143?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:33","pubTimestamp":1787560380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. shed 1.7% to 23.18 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.This was the stock's second consecutive day of losses.BYD Electronic  Co. Ltd. closed 50% below its 52-week high of HK$46.70, which the company achieved Sept. 2.The stock underperformed when compared to some of its competitors, as Times Universal Group Holdings Ltd. rose 5.0%.Trading volume totaled 14.9 million shares, compared to the 50-day average of 11.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00285","LU0348767384.USD","BK1540","BK1607","BK1580","BK1167","LU0274383008.USD","LU0348766576.USD","BK1589","BK1504","BK1582","BK1149","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661497221","title":"CSPC Pharmaceutical Group Stock Climbs 2.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661497221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661497221?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 2.2% to 9.40 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.CSPC Pharmaceutical Group Ltd. closed 19% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.3%, SSY Group Ltd. fell 0.4%, and United Laboratories International Holdings Ltd. fell 0.7%.Trading volume totaled 141.6 million shares, compared to the 50-day average of 98.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","BK1515","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","KURE","LU0067412154.USD","LU1226287875.USD","IE0008368742.USD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YT58.USD","BK1191","HK0000165453.HKD","BK1521","LU0314109678.HKD","LU1008478684.HKD","LU0315179316.USD","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU2039709279.SGD","LU0072913022.USD","LU0140636845.USD","LU1328277881.USD","LU1226288170.HKD","LU1226287792.SGD","LU1951186391.HKD","IE0008369823.USD","LU1226287529.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","IE00B031HY20.USD","IE00B543WZ88.USD","LU1813983027.USD","LU1152091754.HKD","LU1993786604.SGD","LU0501845795.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256221","title":"JD Health International Stock Falls 3.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256221?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slipped 3.5% to 37.32 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.JD Health International Inc. closed 48% short of its 52-week high of HK$71.70, which the company reached Jan. 15.Trading volume totaled 11.3 million shares, compared to the 50-day average of 10.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ62798434.SGD","LU0051755006.USD","BK1591","06618","BK1615","LU0456827905.SGD","86618","BK1247","SGXZ86797644.SGD","BK1142","BK1589","BK1583","BK1571","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221432","title":"Sinopharm Group Stock Falls 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221432","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221432?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 1.9% to 16.33 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.Sinopharm Group Co. Ltd. closed 27% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 3.3%.Trading volume totaled 5.3 million shares, compared to the 50-day average of 5.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK1197","BK1191","BK0183","BK0239","02196","01099","LU0640798160.USD","SHTDY","BK0028","BK1515","BK0196","BK0188","BK1500","BK0060","BK0096","BK0175","LU1115378108.SGD","BK1593","600196","BK0187","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221435","title":"Alibaba Health Information Technology Stock Slips 3.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221435?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:31","pubTimestamp":1787560260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. shed 3.7% to 3.14 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.Alibaba Health Information Technology Ltd. closed 60% below its 52-week high of HK$7.91, which the company achieved Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. fell 1.5%.Trading volume totaled 99.9 million shares, compared to the 50-day average of 108.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1591","BK1501","BK1617","MCHmain","BK1615","00241","HHImain","03115","07500","03419","BK1589","82800","HSTECH","02800","03037","HK0000165453.HKD","BK1515","513600","BK1142","BK1247","BK1502","BK1571","09115","BK1189","07200","HSI","BK1610","BK1584","MHImain","83115","02833","07300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163640448","title":"AH Share Premium Rankings: Market Close Update for August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1163640448","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163640448?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:21","pubTimestamp":1787559710,"startTime":"0","endTime":"0","summary":"As of the closing bell on August 24, the latest AH share premium data has been released, highlighting notable divergences between A-share and H-share valuations across dual-listed companies.Leading...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU0164865239.USD","00042","LU0287142896.SGD","BK1191","LU0737861772.HKD","LU0181495838.USD","LU2039709279.SGD","LU2226246903.HKD","LU3063872942.SGD","03750","LU1244550221.USD","LU0797268264.HKD","LU1244550577.SGD","LU0543330483.HKD","LU0359202008.SGD","IE0032431581.USD","LU2264538146.SGD","BK1122","LU0345780281.USD","03130","BK1166","LU0456827905.SGD","LU1808992512.USD","LU1769817096.USD","LU1244550494.USD","LU0348735423.USD","LU1008478684.HKD","LU1242518931.SGD","LU0607220059.USD","LU1282649067.USD","BK1544","00300","LU1366334651.USD","LU1688375341.USD","LU2008162690.USD","00553","LU0823426308.USD","IE00BVYPNQ40.USD","02359","03328","LU1880383366.USD","LU0455707207.USD","LU0348816934.USD","BK1503","BK1507","LU0348766576.USD","LU0588546209.SGD","01057","SG9999014674.SGD","LU1794554557.SGD","BK1614","BK1209","LU0163747925.USD","HK0000320264.USD","LU0456854461.SGD","03143","02218","00956","LU0516423174.USD","LU1481107354.HKD","BK1514","LU0501845795.SGD","BK1140","LU0531971595.HKD","BK1592","LU0868486357.SGD","LU1152091168.USD","LU0348827113.USD","LU0314109678.HKD","01108","BK1149","LU0329678337.USD","BK1574","LU0072913022.USD","LU0128522157.USD","IE00B543WZ88.USD","03296","IE00B29SXG58.USD","03759","BK1193","BK1231","LU1048596156.SGD","LU0886674414.USD","LU0049853897.USD","LU0640798160.USD","LU0307460666.USD","BK1526","LU0572944931.SGD","IE00BGHQDM52.EUR","LU0862451753.SGD","BK1583","01349","LU0828237940.HKD","LU0254981946.USD","BK1105","LU0359201612.USD","LU1813983027.USD","BK1546","IE00B0169L03.USD","LU0871576103.HKD","LU0516422366.SGD","LU0620787316.HKD","BK1554","LU2242644610.SGD","LU0708995583.HKD","LU1504937902.USD","LU0043850808.USD","00187","HK0000352291.HKD","LU0348767384.USD","SG9999006597.SGD","LU0823426480.USD","LU2097828631.EUR","IE0008369823.USD","IE00BZ08YR35.GBP","LU1282648689.USD","LU0634319403.HKD","LU0384037296.USD","LU0082770016.SGD","LU0540923850.HKD","159982","BK1171","IE00B5MMRT66.SGD","LU0051755006.USD","LU0516423091.SGD","LU0890818403.SGD","LU0348805143.USD","LU0516422440.USD","03986","IE00BZ08YT58.USD","LU1282649810.SGD","BK1610","LU0979878070.USD","LU0210526637.USD","03968","LU2778985437.USD","LU0531970944.HKD","LU1152091754.HKD","02009","LU2394011477.USD","BK1558","LU0164939612.USD","SG9999002463.SGD","LU0326950275.SGD","02475","LU0348814723.USD","LU0828238088.HKD","LU2125910500.SGD","IE0008368742.USD","LU0791591158.USD","02899","LU1064131342.USD","LU0593848301.USD","LU0672654166.SGD","LU0106959298.USD","LU0173614495.USD","BK1163","LU0488056044.USD","LU0918141887.USD","LU0165289439.USD","LU1993786604.SGD","LU0269904917.USD","LU0149534421.HKD","BK1576","LU0370786039.SGD","LU0117841782.USD","06185","BK1564","02701","BK1521","LU0244354667.USD","LU0315179316.USD","LU0214875030.USD","LU0052750758.USD","BK1537","BK1551","LU1328277881.USD","IE0031814852.USD","BK1594","LU0320764755.SGD","BK1116","IE00B031HY20.USD","LU0589944569.HKD","SG9999002828.SGD","LU0329678170.USD","LU0327786744.USD","HK0000306685.HKD","BK1202","LU1719994722.HKD","BK1190","LU2097828714.EUR","00568","LU1831875114.USD","BK1237","SG9999004220.SGD","SG9999001226.SGD","LU0417516738.SGD","LU2045819591.USD","LU0456846285.SGD","HK0000320223.HKD","LU1770034418.SGD","BK1560","02691","HK0001040168.HKD","IE0034224299.USD","LU0266512473.USD","LU1046422090.SGD","LU0211977185.USD","BK1515","IE00BF5LJ272.USD","03678","LU2097828805.USD","01513","LU0561508036.HKD","03308","LU0502904849.HKD","LU1282649141.HKD","LU0516422952.EUR","07233","LU0509642566.USD","LU0140636845.USD","83188","LU0149721374.USD","LU0061477393.USD","LU0039217434.USD","BK1505","LU0231483743.USD","LU1242518857.USD","BK1110","LU2097828557.USD","BK1147","LU0449509016.USD","BK1223","BK1249","LU0106252389.USD","BK1563","LU2177674079.SGD","BK1144","399300","IE00B031J352.USD","LU1807302812.USD","BK1183","LU1988902786.USD","LU0048580855.USD","LU2097828474.EUR","BK1161","LU1115378108.SGD","LU1961090484.USD","LU0431992006.USD","LU0348825331.USD","LU2294711473.HKD","IE00BZ08YS42.EUR","SG9999001093.SGD","HK0000306701.USD","LU2476274720.SGD","LU1251922891.USD","IE00BMCWC346.EUR","00981","02768","BK1607","LU0266512127.USD","02827","IE00BYV24P56.USD","EWH","HK0000352382.USD","LU0082770016.USD","BK1214","LU0164880469.USD","LU0348788117.USD","BK1186","LU0648948544.HKD","BK1552","LU0463099449.HKD","00668","BK1533","IE00B3M56506.USD","LU1023057109.AUD","LU0469268626.HKD","BK1135","LU0417516902.SGD","LU0345780521.USD","LU0328353924.USD","LU2476274308.USD","00317","LU1105468828.SGD","LU1211504680.USD","LU0228367735.SGD","LU2399975544.HKD","83130","SG9999011746.SGD","HK0001040143.USD","LU0228659784.USD","LU0821914370.USD","LU0096374516.USD","03188","BK1522","LU1720050803.USD","LU1769817179.HKD","02846","LU1675838814.USD","LU1366334578.USD","01989","LU0737861699.HKD","BK1205","BK1240","LU0918141705.HKD","LU1303224171.USD","LU0067412154.USD","LU0543330566.HKD","LU0229945570.USD","LU0791590937.USD","IE00BVYPNP33.GBP","01081","BK1170","LU1960683339.HKD","BK1141","01812","LU1880383440.USD","LU0828237510.HKD","BK1198","LU1224709979.USD","LU1226287529.USD","82846","LU0880133367.SGD","LU0359201885.HKD","LU1188198961.HKD","02338","LU0029875118.USD","03200","00895"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125046383","title":"Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1125046383","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125046383?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:46","pubTimestamp":1787557589,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) unveiled its half-year financial report in August 2026, and the mid-year scorecard, which had generated considerable market anticipation, fell...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","LU2097828631.EUR","600276","159938","LU0359201885.HKD","LU1820825898.SGD","LU2289578879.USD","LU2328871848.SGD","LU2543165471.USD","LU1781817850.SGD","LU0359202008.SGD","LU1997245177.USD","BK0239","LU1997245094.SGD","09939","LU2488822045.USD","LU2097828805.USD","LU1255011170.USD","BK1574","LU1064131003.USD","LU2097828714.EUR","BK0188","BK0060","LU2148510915.USD","LU0359201612.USD","BK0196","LU1580142542.USD","LU0405327148.USD","BK1161","LU0405327494.USD","LU2097828474.EUR","01276","BK0028","LU1328615791.USD","BK0183","LU2580892789.USD","LU1997244956.HKD","LU2580892862.HKD","LU2097828557.USD","LU1023057109.AUD","LU1655091616.SGD","BK1191","LU1064130708.USD","LU1969619763.USD","LU1146622755.USD","BK1515","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106235404","title":"Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1106235404","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106235404?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:46","pubTimestamp":1787557578,"startTime":"0","endTime":"0","summary":"Daiwa has issued a research report noting that CSPC Pharma (01093) posted a 40.1% year-on-year increase in interim revenue to RMB 18.59 billion, aligning with its earlier business guidance and the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IE00BZ08YS42.EUR","LU1951186391.HKD","LU2039709279.SGD","LU1328277881.USD","LU0501845795.SGD","LU1960683339.HKD","LU1226287792.SGD","LU1226288253.USD","LU1152091754.HKD","LU1807302812.USD","IE0008369823.USD","LU0315179316.USD","IE0008368742.USD","LU1152091168.USD","BK1515","SG9999004220.SGD","IE00BZ08YT58.USD","LU1993786604.SGD","BK1521","LU0072913022.USD","LU0880133367.SGD","IE00B543WZ88.USD","IE00B031HY20.USD","01093","LU0067412154.USD","LU1813983027.USD","LU0326950275.SGD","KURE","HK0000165453.HKD","LU1008478684.HKD","LU1226287529.USD","EWH","IE00BZ08YR35.GBP","LU1226288170.HKD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1226287875.USD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150872953","title":"Hong Kong Stock Flash | Baiyunshan (00874) Drops Nearly 6% After Results, Net Profit Falls 16.7% in H1 Due to Higher R&D Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=1150872953","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150872953?lang=en_us&edition=fundamental","pubTime":"2026-08-24 14:49","pubTimestamp":1787554167,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) saw its shares tumble nearly 6% in Hong Kong trading following the release of its interim results, with the stock down 5.64% to HK$14.22 at the time of writing, on a turnover of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","600332","BK0096","BK1515","BK4585","BK0239","BK1191","BK0175","KCAI","BK0028","BK0097","00874","BK1606","BK4588","BK1197","BK1521","BK0012","BK0070","BK0183","BK0196","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240309","title":"Ascletis Pharma Slips on Expecting Deeper H1 Loss on R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:43","pubTimestamp":1787542991,"startTime":"0","endTime":"0","summary":"BUZZ-Ascletis Pharma slips on expecting deeper H1 loss on R&D expenses** Shares of Ascletis Pharma Inc1672.HKslip 4.5% to HK$9.565, on track for the biggest one-day pct drop since August 10** The viral diseases and oncology focused pharmaceutical products developerexpects to record net lossof 319.7 million yuan  six months ended in June, as compared with a loss of 88 million yuan the same period a year ago** Company said deeper loss is due to significant increase in research and development expenses as it advances its comprehensive metabolic disease pipeline, including both small molecules and peptides** YTD, stock down 15.9%, while Hang Seng Biotech Index.HSBIOup 9.9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L03A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01672","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661024436","title":"Sinopharm Group's Profit Declines 2% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661024436","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661024436?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:10","pubTimestamp":1787533855,"startTime":"0","endTime":"0","summary":"Sinopharm Group's  profit attributable to owners of the parent fell 1.8% in the first six months of 2026 to 3.40 billion yuan from 3.47 billion yuan a year ago, according to a Monday filing to the Hong Kong stock exchange.Earnings per share declined to 1.09 yuan from 1.11 yuan a year earlier, the pharmaceutical company said.Revenue edged down 1.1% to 282.8 billion yuan from 286.04 billion yuan a year ago.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1197","LU0640798160.USD","LU1115378108.SGD","BK1515","FCA","BK1500","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244886","title":"Guangzhou Baiyunshan Pharma's Profit Falls 17% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244886","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244886?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:04","pubTimestamp":1787533464,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical  posted an attributable net profit of 2.10 billion yuan for the first half of 2026, down 17% from 2.52 billion yuan a year earlier.Earnings per share rose to at 1.289 yuan from 1.548 yuan in the year-ago period, according to a Friday Hong Kong bourse filing.Revenue increased 0.61% year over year to 42.1 billion yuan from 41.8 billion yuan.The company proposed a cash dividend of 0.30 yuan per share, inclusive of tax, to all shareholders.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00874","BK1521","BK0239","BK0188","BK0012","600332","BK1515","BK0028","BK0096","BK1191","BK1197","BK0097","FCA","BK0070","BK1606","BK0196","BK0175","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241804","title":"Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241804","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241804?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:02","pubTimestamp":1787529767,"startTime":"0","endTime":"0","summary":"Sinopharm interim revenue edges down on softness in pharmaceutical distribution businessOverviewChina pharmaceutical distributor's interim revenue declined slightly year-on-yearNet income attributable","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44K04V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4204","BK1587","LU0640798160.USD","BK1161","HK0000320264.USD","BK1230","01099","BK1500","02696","HK0000306685.HKD","HK0000320223.HKD","BK1515","HK0000306701.USD","BK1197","LU1115378108.SGD","HK0000165453.HKD","EDMCQ","BK1574","00656","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224640","title":"Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224640","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661224640?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:22","pubTimestamp":1787523731,"startTime":"0","endTime":"0","summary":"Sinopharm proposes re-election of Lian Wanyong, Yang Binghua as executive directorsSinopharm flagged a board refresh, proposing to re-elect all current directors for a new three-year term starting Sep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nNDL5wd0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1500","LU0640798160.USD","LU1115378108.SGD","BK1197","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246495","title":"Sinopharm Group H1 Revenue RMB 282,799.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246495?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:16","pubTimestamp":1787523367,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nPLXXLTJCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1197","LU0640798160.USD","LU1115378108.SGD","BK1515","BK1500","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246450","title":"Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246450","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246450?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:15","pubTimestamp":1787523312,"startTime":"0","endTime":"0","summary":"Sinopharm H1 net profit drops 2.95% to RMB 5.18 billion; revenue slips 1.13% to RMB 282.8 billionSinopharm posted profit for the period of RMB 5.18 billion, down 2.95% year-on-year; basic EPS slipped ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nNDLdVNSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","LU1115378108.SGD","BK1515","01099","LU0640798160.USD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224557","title":"JD Health International (SEHK:6618) Could Be 43% Undervalued As Half Year Profit Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224557","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661224557?lang=en_us&edition=fundamental","pubTime":"2026-08-24 01:17","pubTimestamp":1787505428,"startTime":"0","endTime":"0","summary":"Why JD Health International’s Latest Earnings Matter For Investors\nJD Health International (SEHK:6618) drew fresh attention after reporting half year 2026 earnings, with higher sales, net income and earnings per share compared with the same period a year earlier.\nSee our latest analysis for JD Health International.\nDespite the stronger half year earnings, JD Health International’s share price tells a mixed story. The stock is at HK$38.66 after a 1 day share price return of 1.63%, yet the year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/jd-health-international-sehk6618-could-be-43-undervalued-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/jd-health-international-sehk6618-could-be-43-undervalued-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SGXZ86797644.SGD","BK1142","BK1589","BK1515","BK1591","LU0456827905.SGD","BK1615","BK1571","86618","06618","BK1247","BK1583","SGXZ62798434.SGD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135663784","title":"Dunhuang's Medical Heritage Blends into Tourism, Boosting Wellness Travel Along the Silk Road","url":"https://stock-news.laohu8.com/highlight/detail?id=1135663784","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135663784?lang=en_us&edition=fundamental","pubTime":"2026-08-23 20:51","pubTimestamp":1787489466,"startTime":"0","endTime":"0","summary":"This summer, the rich tapestry of Dunhuang's medical culture—from the \"moxibustion charts\" painted on its ancient grotto walls to the \"prescription collections\" and the legendary \"immortal porridge\"...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119759096","title":"mRNA Vaccine Breakthrough: From Prevention to Treatment, a Historic Leap in Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1119759096","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119759096?lang=en_us&edition=fundamental","pubTime":"2026-08-23 19:20","pubTimestamp":1787484034,"startTime":"0","endTime":"0","summary":"On August 19, 2026, the pharmaceutical world was set ablaze. US drug giants Moderna and Merck jointly announced the successful Phase III INTerpath-001 clinical trial of their personalized mRNA...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159938","09939","BK1515","MRNX","BK1574","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119594086","title":"Weak Dollar and Shifting Tech Narratives: Strategists Favor Resources and Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1119594086","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119594086?lang=en_us&edition=fundamental","pubTime":"2026-08-23 16:42","pubTimestamp":1787474551,"startTime":"0","endTime":"0","summary":"Founder Securities has released a research report indicating that the market showed a pattern of initial gains followed by losses this week. After a rapid rebound in the early period, major indices...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","TTTN","BK4588","02834","BK1147","09086","159938","UUP","BK1515","VGT","UDN","09939","07266","07261","07568","BK4585","DBND","XLK","BK1161","03086","03034","09834","03455","07522"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":9,"totalSize":283,"code":"91000000","status":"200"}]}}